Retirement Systems of Alabama Sells 7,613 Shares of Encompass Health Corporation $EHC

Retirement Systems of Alabama lowered its stake in Encompass Health Corporation (NYSE:EHC) by 3.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 223,125 shares of the company’s stock after selling 7,613 shares during the period. Retirement Systems of Alabama’s holdings in Encompass Health were worth $27,362,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Keybank National Association OH lifted its position in Encompass Health by 36.7% in the second quarter. Keybank National Association OH now owns 12,683 shares of the company’s stock valued at $1,555,000 after purchasing an additional 3,407 shares during the last quarter. Hantz Financial Services Inc. raised its holdings in Encompass Health by 16,653.8% during the 2nd quarter. Hantz Financial Services Inc. now owns 76,900 shares of the company’s stock valued at $9,430,000 after buying an additional 76,441 shares during the last quarter. Whalen Wealth Management Inc. purchased a new stake in Encompass Health during the 2nd quarter valued at $644,000. Jennison Associates LLC grew its holdings in Encompass Health by 0.3% in the 2nd quarter. Jennison Associates LLC now owns 793,237 shares of the company’s stock worth $97,275,000 after acquiring an additional 2,128 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd increased its position in shares of Encompass Health by 339.3% in the second quarter. Y Intercept Hong Kong Ltd now owns 21,891 shares of the company’s stock valued at $2,684,000 after acquiring an additional 16,908 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Price Performance

Shares of EHC stock opened at $118.04 on Friday. The business’s fifty day moving average is $124.39 and its 200 day moving average is $118.80. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a market cap of $11.89 billion, a price-to-earnings ratio of 22.31, a PEG ratio of 2.20 and a beta of 0.93. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio is 14.87%.

Analyst Ratings Changes

A number of analysts have recently weighed in on EHC shares. Truist Financial increased their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. Bank of America increased their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Finally, UBS Group lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Two analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.